Combs, Daniel
Goodwin, James L.
Quan, Stuart F.
Morgan, Wayne J.
Shetty, Safal
Parthasarathy, Sairam
Article History
Received: 10 December 2015
Accepted: 26 May 2016
First Online: 13 June 2016
Competing interests
: Dr. Parthasarathy reports grants from NIH/NHLBI, grants from Patient Centered Outcomes Research Institute, grants from US Department of Defense, grants from NIH (National Cancer Institute) NCI, grants from US Department of Army, grants from Johrei Institute, personal fees from American Academy of Sleep Medicine, personal fees from American College of Chest Physicians, personal fees from UpToDate Inc., personal fees from Philips-Respironics, Inc. and Vapotherm Inc., grants from Younes Sleep Technologies, Ltd., grants from Niveus Medical Inc., grants from Philips-Respironics, Inc., outside the submitted work. Dr. Parthasarathy reports non-financial support from National Center for Sleep Disorders Research of the NIH (NHLBI) and patents UA 14-018 U.S.S.N. 61/884,654; PTAS 502570970 (Home breathing device) pending. Dr. Wayne Morgan has received grant funding from NIH and the Cystic Fibrosis Foundation and is a consultant to the Cystic Fibrosis Foundation and Genentech. These are all unrelated to the topic of this paper. Dr. Stuart F. Quan reports grants from the NIH/NIA, American Diabetes Association and the National Science Foundation and consults for Global Corporate Challenge and the American Board of Internal Medicine.